Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel
Last Updated : Jul 18, 2016 01:52 PM IST | Source: Moneycontrol.com

Strides Shasun Q1 PAT seen down by 8.9% at Rs 87.6 cr: Religare

Sales are expected to decrease by 4.7 percent Q-o-Q (up 58.3 percent Y-o-Y) to Rs 955.0 crore, according to Religare Research.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More
Religare Research has come out with its first quarter (April-June) earnings estimates for the India Pharmaceuticals sector. The brokerage house expects Strides Shasun to report a degrowth of 8.9 percent quarter-on-quarter (up of 91.9 percent year-on-year) in net profit at Rs 87.6 crore.

Sales are expected to decrease by 4.7 percent Q-o-Q (up 58.3 percent Y-o-Y) to Rs 955.0 crore, according to Religare Research.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 5.3 percent Q-o-Q (up 111.9 percent Y-o-Y) to Rs 179.5 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Jul 16, 2016 01:09 pm
Sections